Diagnostic performance of multimodal biomarkers in colorectal cancer

Key Points

• The study demonstrates enhanced diagnostic performance of multimodal biomarkers in colorectal cancer.
• Key evidence includes a sensitivity of 90% and specificity of 85% in early detection of tumors.
• The analysis utilized comprehensive biomarker profiling across diverse patient cohorts to assess performance accuracy.
• These findings may enable more accurate colorectal cancer diagnoses, prompting further research into clinical applications.